nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLC22A2—Memantine—Alzheimer's disease	0.289	1	CbGbCtD
Dinoprostone—SLC22A8—choroid plexus—Alzheimer's disease	0.0215	0.138	CbGeAlD
Dinoprostone—Presyncope—Rivastigmine—Alzheimer's disease	0.00821	0.0291	CcSEcCtD
Dinoprostone—PTGIR—blood vessel—Alzheimer's disease	0.00567	0.0364	CbGeAlD
Dinoprostone—HPGDS—embryo—Alzheimer's disease	0.00415	0.0266	CbGeAlD
Dinoprostone—PTGER3—telencephalon—Alzheimer's disease	0.0039	0.0251	CbGeAlD
Dinoprostone—Hiccups—Galantamine—Alzheimer's disease	0.00379	0.0134	CcSEcCtD
Dinoprostone—Laryngitis—Memantine—Alzheimer's disease	0.0037	0.0131	CcSEcCtD
Dinoprostone—HPGDS—forebrain—Alzheimer's disease	0.00367	0.0236	CbGeAlD
Dinoprostone—Laryngitis—Rivastigmine—Alzheimer's disease	0.00362	0.0128	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Galantamine—Alzheimer's disease	0.00348	0.0123	CcSEcCtD
Dinoprostone—HPGDS—telencephalon—Alzheimer's disease	0.00337	0.0217	CbGeAlD
Dinoprostone—Hypertonia—Galantamine—Alzheimer's disease	0.00333	0.0118	CcSEcCtD
Dinoprostone—Skin discolouration—Donepezil—Alzheimer's disease	0.00325	0.0115	CcSEcCtD
Dinoprostone—Hearing impaired—Donepezil—Alzheimer's disease	0.00309	0.0109	CcSEcCtD
Dinoprostone—SLCO1C1—forebrain—Alzheimer's disease	0.003	0.0193	CbGeAlD
Dinoprostone—PTGIR—forebrain—Alzheimer's disease	0.00299	0.0192	CbGeAlD
Dinoprostone—Vaginal inflammation—Donepezil—Alzheimer's disease	0.00294	0.0104	CcSEcCtD
Dinoprostone—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.00291	0.0103	CcSEcCtD
Dinoprostone—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00289	0.0102	CcSEcCtD
Dinoprostone—Wheezing—Donepezil—Alzheimer's disease	0.00285	0.0101	CcSEcCtD
Dinoprostone—Hearing impaired—Memantine—Alzheimer's disease	0.0028	0.00992	CcSEcCtD
Dinoprostone—Vaginal infection—Donepezil—Alzheimer's disease	0.00278	0.00982	CcSEcCtD
Dinoprostone—SLCO1C1—telencephalon—Alzheimer's disease	0.00276	0.0177	CbGeAlD
Dinoprostone—PTGIR—telencephalon—Alzheimer's disease	0.00275	0.0177	CbGeAlD
Dinoprostone—PTGER4—nervous system—Alzheimer's disease	0.00272	0.0175	CbGeAlD
Dinoprostone—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.0027	0.00956	CcSEcCtD
Dinoprostone—Inflammation—Rivastigmine—Alzheimer's disease	0.00269	0.00953	CcSEcCtD
Dinoprostone—SLC51A—nervous system—Alzheimer's disease	0.00267	0.0172	CbGeAlD
Dinoprostone—PTGER1—nervous system—Alzheimer's disease	0.00263	0.0169	CbGeAlD
Dinoprostone—PTGER4—central nervous system—Alzheimer's disease	0.00262	0.0168	CbGeAlD
Dinoprostone—Urinary retention—Galantamine—Alzheimer's disease	0.00262	0.00927	CcSEcCtD
Dinoprostone—Hiccups—Rivastigmine—Alzheimer's disease	0.00261	0.00924	CcSEcCtD
Dinoprostone—Vaginal inflammation—Rivastigmine—Alzheimer's disease	0.00261	0.00924	CcSEcCtD
Dinoprostone—Hypertonia—Donepezil—Alzheimer's disease	0.00258	0.00912	CcSEcCtD
Dinoprostone—SLC51A—central nervous system—Alzheimer's disease	0.00257	0.0165	CbGeAlD
Dinoprostone—Dehydration—Galantamine—Alzheimer's disease	0.00256	0.00906	CcSEcCtD
Dinoprostone—PTGER1—central nervous system—Alzheimer's disease	0.00253	0.0163	CbGeAlD
Dinoprostone—Vaginal infection—Rivastigmine—Alzheimer's disease	0.00247	0.00873	CcSEcCtD
Dinoprostone—SLCO4A1—forebrain—Alzheimer's disease	0.0024	0.0154	CbGeAlD
Dinoprostone—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.0024	0.00849	CcSEcCtD
Dinoprostone—Hypertonia—Memantine—Alzheimer's disease	0.00234	0.00828	CcSEcCtD
Dinoprostone—PTGER3—nervous system—Alzheimer's disease	0.0023	0.0148	CbGeAlD
Dinoprostone—Hypertonia—Rivastigmine—Alzheimer's disease	0.00229	0.0081	CcSEcCtD
Dinoprostone—Hot flush—Donepezil—Alzheimer's disease	0.00228	0.00807	CcSEcCtD
Dinoprostone—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00226	0.008	CcSEcCtD
Dinoprostone—PTGER3—central nervous system—Alzheimer's disease	0.00222	0.0143	CbGeAlD
Dinoprostone—SLCO4A1—telencephalon—Alzheimer's disease	0.00221	0.0142	CbGeAlD
Dinoprostone—ABCC5—telencephalon—Alzheimer's disease	0.0022	0.0141	CbGeAlD
Dinoprostone—Deafness—Memantine—Alzheimer's disease	0.00217	0.00767	CcSEcCtD
Dinoprostone—Eye pain—Memantine—Alzheimer's disease	0.00215	0.0076	CcSEcCtD
Dinoprostone—Deafness—Rivastigmine—Alzheimer's disease	0.00212	0.0075	CcSEcCtD
Dinoprostone—Eye pain—Rivastigmine—Alzheimer's disease	0.0021	0.00743	CcSEcCtD
Dinoprostone—PTGER4—brain—Alzheimer's disease	0.00208	0.0134	CbGeAlD
Dinoprostone—Hot flush—Memantine—Alzheimer's disease	0.00207	0.00733	CcSEcCtD
Dinoprostone—Menopausal symptoms—Memantine—Alzheimer's disease	0.00205	0.00727	CcSEcCtD
Dinoprostone—SLC51A—brain—Alzheimer's disease	0.00204	0.0131	CbGeAlD
Dinoprostone—Urinary retention—Donepezil—Alzheimer's disease	0.00203	0.00718	CcSEcCtD
Dinoprostone—Hot flush—Rivastigmine—Alzheimer's disease	0.00203	0.00717	CcSEcCtD
Dinoprostone—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00201	0.00711	CcSEcCtD
Dinoprostone—HPGDS—nervous system—Alzheimer's disease	0.00199	0.0128	CbGeAlD
Dinoprostone—Dehydration—Donepezil—Alzheimer's disease	0.00198	0.00702	CcSEcCtD
Dinoprostone—Cramp muscle—Donepezil—Alzheimer's disease	0.00192	0.0068	CcSEcCtD
Dinoprostone—HPGDS—central nervous system—Alzheimer's disease	0.00192	0.0123	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS1—Alzheimer's disease	0.00189	0.636	CrCbGaD
Dinoprostone—SLCO2B1—forebrain—Alzheimer's disease	0.00187	0.012	CbGeAlD
Dinoprostone—Asthma—Donepezil—Alzheimer's disease	0.00184	0.00653	CcSEcCtD
Dinoprostone—Cardiac arrest—Memantine—Alzheimer's disease	0.00184	0.00652	CcSEcCtD
Dinoprostone—Urinary retention—Memantine—Alzheimer's disease	0.00184	0.00652	CcSEcCtD
Dinoprostone—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.0018	0.00638	CcSEcCtD
Dinoprostone—Urinary retention—Rivastigmine—Alzheimer's disease	0.0018	0.00638	CcSEcCtD
Dinoprostone—Dehydration—Memantine—Alzheimer's disease	0.0018	0.00638	CcSEcCtD
Dinoprostone—Sweating increased—Donepezil—Alzheimer's disease	0.0018	0.00636	CcSEcCtD
Dinoprostone—SLC22A1—forebrain—Alzheimer's disease	0.00179	0.0115	CbGeAlD
Dinoprostone—Flushing—Galantamine—Alzheimer's disease	0.00177	0.00626	CcSEcCtD
Dinoprostone—Dehydration—Rivastigmine—Alzheimer's disease	0.00176	0.00624	CcSEcCtD
Dinoprostone—PTGER3—brain—Alzheimer's disease	0.00176	0.0113	CbGeAlD
Dinoprostone—Angiopathy—Galantamine—Alzheimer's disease	0.00173	0.00612	CcSEcCtD
Dinoprostone—SLCO1A2—forebrain—Alzheimer's disease	0.00172	0.0111	CbGeAlD
Dinoprostone—SLCO2B1—telencephalon—Alzheimer's disease	0.00172	0.0111	CbGeAlD
Dinoprostone—Immune system disorder—Galantamine—Alzheimer's disease	0.00172	0.00609	CcSEcCtD
Dinoprostone—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00171	0.00604	CcSEcCtD
Dinoprostone—Arrhythmia—Galantamine—Alzheimer's disease	0.0017	0.00602	CcSEcCtD
Dinoprostone—CYP19A1—forebrain—Alzheimer's disease	0.00168	0.0108	CbGeAlD
Dinoprostone—Asthma—Memantine—Alzheimer's disease	0.00167	0.00593	CcSEcCtD
Dinoprostone—ABCC4—forebrain—Alzheimer's disease	0.00166	0.0106	CbGeAlD
Dinoprostone—Bronchospasm—Memantine—Alzheimer's disease	0.00165	0.00583	CcSEcCtD
Dinoprostone—SLC22A1—telencephalon—Alzheimer's disease	0.00164	0.0106	CbGeAlD
Dinoprostone—Sweating increased—Memantine—Alzheimer's disease	0.00163	0.00577	CcSEcCtD
Dinoprostone—SLCO1C1—nervous system—Alzheimer's disease	0.00163	0.0105	CbGeAlD
Dinoprostone—Tension—Galantamine—Alzheimer's disease	0.00163	0.00576	CcSEcCtD
Dinoprostone—PTGIR—nervous system—Alzheimer's disease	0.00162	0.0104	CbGeAlD
Dinoprostone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00162	0.00574	CcSEcCtD
Dinoprostone—Myocardial infarction—Donepezil—Alzheimer's disease	0.00161	0.00571	CcSEcCtD
Dinoprostone—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00161	0.0057	CcSEcCtD
Dinoprostone—Back pain—Galantamine—Alzheimer's disease	0.0016	0.00568	CcSEcCtD
Dinoprostone—Sweating increased—Rivastigmine—Alzheimer's disease	0.0016	0.00565	CcSEcCtD
Dinoprostone—Muscle spasms—Galantamine—Alzheimer's disease	0.00159	0.00564	CcSEcCtD
Dinoprostone—SLCO1A2—telencephalon—Alzheimer's disease	0.00158	0.0102	CbGeAlD
Dinoprostone—SLCO1C1—central nervous system—Alzheimer's disease	0.00157	0.0101	CbGeAlD
Dinoprostone—PTGIR—central nervous system—Alzheimer's disease	0.00156	0.01	CbGeAlD
Dinoprostone—Vision blurred—Galantamine—Alzheimer's disease	0.00156	0.00553	CcSEcCtD
Dinoprostone—Tremor—Galantamine—Alzheimer's disease	0.00155	0.0055	CcSEcCtD
Dinoprostone—PTGIR—cerebellum—Alzheimer's disease	0.00153	0.00981	CbGeAlD
Dinoprostone—HPGDS—brain—Alzheimer's disease	0.00152	0.00978	CbGeAlD
Dinoprostone—Syncope—Galantamine—Alzheimer's disease	0.00149	0.00526	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00147	0.00521	CcSEcCtD
Dinoprostone—Pharyngitis—Donepezil—Alzheimer's disease	0.00147	0.00519	CcSEcCtD
Dinoprostone—Myocardial infarction—Memantine—Alzheimer's disease	0.00146	0.00518	CcSEcCtD
Dinoprostone—Loss of consciousness—Galantamine—Alzheimer's disease	0.00146	0.00516	CcSEcCtD
Dinoprostone—Cough—Galantamine—Alzheimer's disease	0.00145	0.00512	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00144	0.0051	CcSEcCtD
Dinoprostone—SLCO3A1—nervous system—Alzheimer's disease	0.00143	0.0092	CbGeAlD
Dinoprostone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00143	0.00507	CcSEcCtD
Dinoprostone—Hypertension—Galantamine—Alzheimer's disease	0.00143	0.00507	CcSEcCtD
Dinoprostone—SLCO2A1—nervous system—Alzheimer's disease	0.00142	0.00912	CbGeAlD
Dinoprostone—Arthralgia—Galantamine—Alzheimer's disease	0.00141	0.005	CcSEcCtD
Dinoprostone—Myalgia—Galantamine—Alzheimer's disease	0.00141	0.005	CcSEcCtD
Dinoprostone—Chest pain—Galantamine—Alzheimer's disease	0.00141	0.005	CcSEcCtD
Dinoprostone—CYP11A1—nervous system—Alzheimer's disease	0.0014	0.00902	CbGeAlD
Dinoprostone—SLCO3A1—central nervous system—Alzheimer's disease	0.00138	0.00886	CbGeAlD
Dinoprostone—SLCO2A1—central nervous system—Alzheimer's disease	0.00137	0.00878	CbGeAlD
Dinoprostone—CYP11A1—central nervous system—Alzheimer's disease	0.00135	0.00868	CbGeAlD
Dinoprostone—SLCO3A1—cerebellum—Alzheimer's disease	0.00135	0.00866	CbGeAlD
Dinoprostone—Shock—Galantamine—Alzheimer's disease	0.00133	0.00471	CcSEcCtD
Dinoprostone—Pharyngitis—Memantine—Alzheimer's disease	0.00133	0.00471	CcSEcCtD
Dinoprostone—Chills—Donepezil—Alzheimer's disease	0.00132	0.00469	CcSEcCtD
Dinoprostone—Tachycardia—Galantamine—Alzheimer's disease	0.00132	0.00467	CcSEcCtD
Dinoprostone—Arrhythmia—Donepezil—Alzheimer's disease	0.00132	0.00467	CcSEcCtD
Dinoprostone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00131	0.00463	CcSEcCtD
Dinoprostone—SLCO4A1—nervous system—Alzheimer's disease	0.00131	0.00838	CbGeAlD
Dinoprostone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.0013	0.00461	CcSEcCtD
Dinoprostone—Hypotension—Galantamine—Alzheimer's disease	0.00126	0.00448	CcSEcCtD
Dinoprostone—Tension—Donepezil—Alzheimer's disease	0.00126	0.00446	CcSEcCtD
Dinoprostone—SLCO4A1—central nervous system—Alzheimer's disease	0.00126	0.00807	CbGeAlD
Dinoprostone—SLCO1C1—brain—Alzheimer's disease	0.00125	0.008	CbGeAlD
Dinoprostone—Flushing—Memantine—Alzheimer's disease	0.00124	0.0044	CcSEcCtD
Dinoprostone—Back pain—Donepezil—Alzheimer's disease	0.00124	0.0044	CcSEcCtD
Dinoprostone—PTGIR—brain—Alzheimer's disease	0.00124	0.00797	CbGeAlD
Dinoprostone—Muscle spasms—Donepezil—Alzheimer's disease	0.00124	0.00437	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00123	0.00436	CcSEcCtD
Dinoprostone—SLCO4A1—cerebellum—Alzheimer's disease	0.00123	0.00789	CbGeAlD
Dinoprostone—ABCC5—cerebellum—Alzheimer's disease	0.00122	0.00785	CbGeAlD
Dinoprostone—Flushing—Rivastigmine—Alzheimer's disease	0.00122	0.00431	CcSEcCtD
Dinoprostone—Angiopathy—Memantine—Alzheimer's disease	0.00122	0.0043	CcSEcCtD
Dinoprostone—Paraesthesia—Galantamine—Alzheimer's disease	0.00122	0.0043	CcSEcCtD
Dinoprostone—Vision blurred—Donepezil—Alzheimer's disease	0.00121	0.00429	CcSEcCtD
Dinoprostone—Immune system disorder—Memantine—Alzheimer's disease	0.00121	0.00429	CcSEcCtD
Dinoprostone—Tremor—Donepezil—Alzheimer's disease	0.0012	0.00426	CcSEcCtD
Dinoprostone—Chills—Memantine—Alzheimer's disease	0.0012	0.00426	CcSEcCtD
Dinoprostone—Arrhythmia—Memantine—Alzheimer's disease	0.0012	0.00424	CcSEcCtD
Dinoprostone—Angiopathy—Rivastigmine—Alzheimer's disease	0.00119	0.00421	CcSEcCtD
Dinoprostone—SLC22A7—brain—Alzheimer's disease	0.00118	0.00758	CbGeAlD
Dinoprostone—Chills—Rivastigmine—Alzheimer's disease	0.00118	0.00416	CcSEcCtD
Dinoprostone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00117	0.00415	CcSEcCtD
Dinoprostone—Syncope—Donepezil—Alzheimer's disease	0.00115	0.00408	CcSEcCtD
Dinoprostone—Tension—Memantine—Alzheimer's disease	0.00115	0.00405	CcSEcCtD
Dinoprostone—SLC22A6—brain—Alzheimer's disease	0.00114	0.00732	CbGeAlD
Dinoprostone—Loss of consciousness—Donepezil—Alzheimer's disease	0.00113	0.004	CcSEcCtD
Dinoprostone—Back pain—Memantine—Alzheimer's disease	0.00113	0.00399	CcSEcCtD
Dinoprostone—Cough—Donepezil—Alzheimer's disease	0.00112	0.00397	CcSEcCtD
Dinoprostone—Tension—Rivastigmine—Alzheimer's disease	0.00112	0.00396	CcSEcCtD
Dinoprostone—Hypertension—Donepezil—Alzheimer's disease	0.00111	0.00393	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00111	0.00392	CcSEcCtD
Dinoprostone—Back pain—Rivastigmine—Alzheimer's disease	0.0011	0.00391	CcSEcCtD
Dinoprostone—Vision blurred—Memantine—Alzheimer's disease	0.0011	0.00389	CcSEcCtD
Dinoprostone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0011	0.00388	CcSEcCtD
Dinoprostone—SLCO3A1—brain—Alzheimer's disease	0.0011	0.00703	CbGeAlD
Dinoprostone—Myalgia—Donepezil—Alzheimer's disease	0.00109	0.00387	CcSEcCtD
Dinoprostone—Arthralgia—Donepezil—Alzheimer's disease	0.00109	0.00387	CcSEcCtD
Dinoprostone—Chest pain—Donepezil—Alzheimer's disease	0.00109	0.00387	CcSEcCtD
Dinoprostone—Tremor—Memantine—Alzheimer's disease	0.00109	0.00387	CcSEcCtD
Dinoprostone—SLCO2A1—brain—Alzheimer's disease	0.00108	0.00697	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—Alzheimer's disease	0.00108	0.364	CrCbGaD
Dinoprostone—Vision blurred—Rivastigmine—Alzheimer's disease	0.00108	0.00381	CcSEcCtD
Dinoprostone—CYP11A1—brain—Alzheimer's disease	0.00107	0.00689	CbGeAlD
Dinoprostone—Abdominal pain—Galantamine—Alzheimer's disease	0.00107	0.00379	CcSEcCtD
Dinoprostone—Body temperature increased—Galantamine—Alzheimer's disease	0.00107	0.00379	CcSEcCtD
Dinoprostone—Tremor—Rivastigmine—Alzheimer's disease	0.00107	0.00379	CcSEcCtD
Dinoprostone—Syncope—Memantine—Alzheimer's disease	0.00105	0.0037	CcSEcCtD
Dinoprostone—Shock—Donepezil—Alzheimer's disease	0.00103	0.00365	CcSEcCtD
Dinoprostone—Loss of consciousness—Memantine—Alzheimer's disease	0.00103	0.00363	CcSEcCtD
Dinoprostone—Syncope—Rivastigmine—Alzheimer's disease	0.00102	0.00362	CcSEcCtD
Dinoprostone—Cough—Memantine—Alzheimer's disease	0.00102	0.0036	CcSEcCtD
Dinoprostone—SLCO2B1—nervous system—Alzheimer's disease	0.00102	0.00652	CbGeAlD
Dinoprostone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00101	0.00359	CcSEcCtD
Dinoprostone—Hypertension—Memantine—Alzheimer's disease	0.00101	0.00357	CcSEcCtD
Dinoprostone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.001	0.00355	CcSEcCtD
Dinoprostone—SLCO4A1—brain—Alzheimer's disease	0.000998	0.00641	CbGeAlD
Dinoprostone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000997	0.00353	CcSEcCtD
Dinoprostone—Cough—Rivastigmine—Alzheimer's disease	0.000996	0.00353	CcSEcCtD
Dinoprostone—Arthralgia—Memantine—Alzheimer's disease	0.000993	0.00352	CcSEcCtD
Dinoprostone—Chest pain—Memantine—Alzheimer's disease	0.000993	0.00352	CcSEcCtD
Dinoprostone—Myalgia—Memantine—Alzheimer's disease	0.000993	0.00352	CcSEcCtD
Dinoprostone—ABCC5—brain—Alzheimer's disease	0.000992	0.00637	CbGeAlD
Dinoprostone—Hypertension—Rivastigmine—Alzheimer's disease	0.000986	0.00349	CcSEcCtD
Dinoprostone—Hypotension—Donepezil—Alzheimer's disease	0.00098	0.00347	CcSEcCtD
Dinoprostone—SLCO2B1—central nervous system—Alzheimer's disease	0.000978	0.00628	CbGeAlD
Dinoprostone—Chest pain—Rivastigmine—Alzheimer's disease	0.000972	0.00344	CcSEcCtD
Dinoprostone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000972	0.00344	CcSEcCtD
Dinoprostone—Myalgia—Rivastigmine—Alzheimer's disease	0.000972	0.00344	CcSEcCtD
Dinoprostone—Asthenia—Galantamine—Alzheimer's disease	0.000971	0.00344	CcSEcCtD
Dinoprostone—SLC22A1—nervous system—Alzheimer's disease	0.000971	0.00624	CbGeAlD
Dinoprostone—SLCO2B1—cerebellum—Alzheimer's disease	0.000956	0.00614	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000956	0.00338	CcSEcCtD
Dinoprostone—Paraesthesia—Donepezil—Alzheimer's disease	0.000942	0.00333	CcSEcCtD
Dinoprostone—Shock—Memantine—Alzheimer's disease	0.000937	0.00332	CcSEcCtD
Dinoprostone—Dyspnoea—Donepezil—Alzheimer's disease	0.000935	0.00331	CcSEcCtD
Dinoprostone—SLCO1A2—nervous system—Alzheimer's disease	0.000935	0.006	CbGeAlD
Dinoprostone—SLC22A1—central nervous system—Alzheimer's disease	0.000935	0.006	CbGeAlD
Dinoprostone—Tachycardia—Memantine—Alzheimer's disease	0.000929	0.00329	CcSEcCtD
Dinoprostone—Diarrhoea—Galantamine—Alzheimer's disease	0.000926	0.00328	CcSEcCtD
Dinoprostone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000921	0.00326	CcSEcCtD
Dinoprostone—Shock—Rivastigmine—Alzheimer's disease	0.000917	0.00324	CcSEcCtD
Dinoprostone—CYP19A1—nervous system—Alzheimer's disease	0.000912	0.00586	CbGeAlD
Dinoprostone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000909	0.00322	CcSEcCtD
Dinoprostone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000901	0.00319	CcSEcCtD
Dinoprostone—SLCO1A2—central nervous system—Alzheimer's disease	0.0009	0.00578	CbGeAlD
Dinoprostone—ABCC4—nervous system—Alzheimer's disease	0.0009	0.00578	CbGeAlD
Dinoprostone—Pain—Donepezil—Alzheimer's disease	0.000897	0.00317	CcSEcCtD
Dinoprostone—Dizziness—Galantamine—Alzheimer's disease	0.000895	0.00317	CcSEcCtD
Dinoprostone—SLC22A8—nervous system—Alzheimer's disease	0.000893	0.00573	CbGeAlD
Dinoprostone—Hypotension—Memantine—Alzheimer's disease	0.00089	0.00315	CcSEcCtD
Dinoprostone—SLCO1A2—cerebellum—Alzheimer's disease	0.00088	0.00565	CbGeAlD
Dinoprostone—CYP19A1—central nervous system—Alzheimer's disease	0.000878	0.00564	CbGeAlD
Dinoprostone—Hypotension—Rivastigmine—Alzheimer's disease	0.000871	0.00308	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000868	0.00307	CcSEcCtD
Dinoprostone—ABCC4—central nervous system—Alzheimer's disease	0.000866	0.00556	CbGeAlD
Dinoprostone—Vomiting—Galantamine—Alzheimer's disease	0.00086	0.00305	CcSEcCtD
Dinoprostone—SLC22A8—central nervous system—Alzheimer's disease	0.000859	0.00552	CbGeAlD
Dinoprostone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000858	0.00304	CcSEcCtD
Dinoprostone—Paraesthesia—Memantine—Alzheimer's disease	0.000855	0.00303	CcSEcCtD
Dinoprostone—Rash—Galantamine—Alzheimer's disease	0.000853	0.00302	CcSEcCtD
Dinoprostone—Dermatitis—Galantamine—Alzheimer's disease	0.000853	0.00302	CcSEcCtD
Dinoprostone—Dyspnoea—Memantine—Alzheimer's disease	0.000849	0.003	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000849	0.003	CcSEcCtD
Dinoprostone—Headache—Galantamine—Alzheimer's disease	0.000848	0.003	CcSEcCtD
Dinoprostone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000837	0.00296	CcSEcCtD
Dinoprostone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000831	0.00294	CcSEcCtD
Dinoprostone—Body temperature increased—Donepezil—Alzheimer's disease	0.000829	0.00293	CcSEcCtD
Dinoprostone—Abdominal pain—Donepezil—Alzheimer's disease	0.000829	0.00293	CcSEcCtD
Dinoprostone—Pain—Memantine—Alzheimer's disease	0.000814	0.00288	CcSEcCtD
Dinoprostone—Nausea—Galantamine—Alzheimer's disease	0.000804	0.00285	CcSEcCtD
Dinoprostone—Pain—Rivastigmine—Alzheimer's disease	0.000797	0.00282	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000779	0.00276	CcSEcCtD
Dinoprostone—SLCO2B1—brain—Alzheimer's disease	0.000776	0.00499	CbGeAlD
Dinoprostone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000773	0.00273	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000762	0.0027	CcSEcCtD
Dinoprostone—Abdominal pain—Memantine—Alzheimer's disease	0.000753	0.00266	CcSEcCtD
Dinoprostone—Body temperature increased—Memantine—Alzheimer's disease	0.000753	0.00266	CcSEcCtD
Dinoprostone—Asthenia—Donepezil—Alzheimer's disease	0.000753	0.00266	CcSEcCtD
Dinoprostone—SLC22A1—brain—Alzheimer's disease	0.000742	0.00477	CbGeAlD
Dinoprostone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000736	0.00261	CcSEcCtD
Dinoprostone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000736	0.00261	CcSEcCtD
Dinoprostone—Diarrhoea—Donepezil—Alzheimer's disease	0.000718	0.00254	CcSEcCtD
Dinoprostone—SLCO1A2—brain—Alzheimer's disease	0.000715	0.00459	CbGeAlD
Dinoprostone—Hypersensitivity—Memantine—Alzheimer's disease	0.000702	0.00248	CcSEcCtD
Dinoprostone—CYP19A1—brain—Alzheimer's disease	0.000697	0.00448	CbGeAlD
Dinoprostone—Dizziness—Donepezil—Alzheimer's disease	0.000694	0.00245	CcSEcCtD
Dinoprostone—ABCC4—brain—Alzheimer's disease	0.000688	0.00442	CbGeAlD
Dinoprostone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000686	0.00243	CcSEcCtD
Dinoprostone—Asthenia—Memantine—Alzheimer's disease	0.000683	0.00242	CcSEcCtD
Dinoprostone—SLC22A8—brain—Alzheimer's disease	0.000682	0.00438	CbGeAlD
Dinoprostone—Asthenia—Rivastigmine—Alzheimer's disease	0.000668	0.00237	CcSEcCtD
Dinoprostone—Vomiting—Donepezil—Alzheimer's disease	0.000667	0.00236	CcSEcCtD
Dinoprostone—Rash—Donepezil—Alzheimer's disease	0.000661	0.00234	CcSEcCtD
Dinoprostone—Dermatitis—Donepezil—Alzheimer's disease	0.000661	0.00234	CcSEcCtD
Dinoprostone—Headache—Donepezil—Alzheimer's disease	0.000657	0.00233	CcSEcCtD
Dinoprostone—Diarrhoea—Memantine—Alzheimer's disease	0.000652	0.00231	CcSEcCtD
Dinoprostone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000637	0.00226	CcSEcCtD
Dinoprostone—Dizziness—Memantine—Alzheimer's disease	0.00063	0.00223	CcSEcCtD
Dinoprostone—Nausea—Donepezil—Alzheimer's disease	0.000623	0.0022	CcSEcCtD
Dinoprostone—Dizziness—Rivastigmine—Alzheimer's disease	0.000616	0.00218	CcSEcCtD
Dinoprostone—Vomiting—Memantine—Alzheimer's disease	0.000605	0.00214	CcSEcCtD
Dinoprostone—Rash—Memantine—Alzheimer's disease	0.0006	0.00213	CcSEcCtD
Dinoprostone—Dermatitis—Memantine—Alzheimer's disease	0.0006	0.00212	CcSEcCtD
Dinoprostone—Headache—Memantine—Alzheimer's disease	0.000597	0.00211	CcSEcCtD
Dinoprostone—Vomiting—Rivastigmine—Alzheimer's disease	0.000592	0.0021	CcSEcCtD
Dinoprostone—Rash—Rivastigmine—Alzheimer's disease	0.000587	0.00208	CcSEcCtD
Dinoprostone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000587	0.00208	CcSEcCtD
Dinoprostone—Headache—Rivastigmine—Alzheimer's disease	0.000584	0.00207	CcSEcCtD
Dinoprostone—Nausea—Memantine—Alzheimer's disease	0.000566	0.002	CcSEcCtD
Dinoprostone—Nausea—Rivastigmine—Alzheimer's disease	0.000553	0.00196	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—NOS3—Alzheimer's disease	2.31e-05	8.58e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—LEP—Alzheimer's disease	2.31e-05	8.57e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APOE—Alzheimer's disease	2.31e-05	8.57e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CAV1—Alzheimer's disease	2.3e-05	8.55e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—AKT1—Alzheimer's disease	2.29e-05	8.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.29e-05	8.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.29e-05	8.5e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CAV1—Alzheimer's disease	2.29e-05	8.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS1—Alzheimer's disease	2.28e-05	8.47e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO1—Alzheimer's disease	2.28e-05	8.47e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ABCA1—Alzheimer's disease	2.27e-05	8.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CALM1—Alzheimer's disease	2.27e-05	8.42e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CALM1—Alzheimer's disease	2.27e-05	8.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—LEP—Alzheimer's disease	2.26e-05	8.39e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APOE—Alzheimer's disease	2.26e-05	8.39e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—LEP—Alzheimer's disease	2.26e-05	8.39e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APOE—Alzheimer's disease	2.26e-05	8.39e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.24e-05	8.32e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CAV1—Alzheimer's disease	2.24e-05	8.31e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CAV1—Alzheimer's disease	2.24e-05	8.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP2D6—Alzheimer's disease	2.24e-05	8.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ACHE—Alzheimer's disease	2.23e-05	8.28e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	2.2e-05	8.18e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ESR1—Alzheimer's disease	2.2e-05	8.18e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—Alzheimer's disease	2.2e-05	8.16e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—MTHFR—Alzheimer's disease	2.19e-05	8.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.18e-05	8.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.18e-05	8.11e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—F2—Alzheimer's disease	2.18e-05	8.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.16e-05	8.01e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ESR1—Alzheimer's disease	2.16e-05	8.01e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ESR1—Alzheimer's disease	2.16e-05	8.01e-05	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.15e-05	7.97e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—Alzheimer's disease	2.14e-05	7.96e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—F2—Alzheimer's disease	2.13e-05	7.91e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—F2—Alzheimer's disease	2.13e-05	7.91e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	2.13e-05	7.91e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CASP3—Alzheimer's disease	2.13e-05	7.9e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BCHE—Alzheimer's disease	2.12e-05	7.87e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.11e-05	7.85e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-05	7.85e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.09e-05	7.77e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	2.09e-05	7.76e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO1—Alzheimer's disease	2.09e-05	7.76e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.08e-05	7.74e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOTCH1—Alzheimer's disease	2.08e-05	7.74e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ACHE—Alzheimer's disease	2.08e-05	7.72e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NOS3—Alzheimer's disease	2.08e-05	7.72e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.07e-05	7.7e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INPP5D—Alzheimer's disease	2.05e-05	7.63e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	2.05e-05	7.61e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.05e-05	7.61e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.05e-05	7.6e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CALM1—Alzheimer's disease	2.04e-05	7.58e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—APOE—Alzheimer's disease	2.03e-05	7.55e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PPARG—Alzheimer's disease	2.02e-05	7.51e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—Alzheimer's disease	2.02e-05	7.49e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CAV1—Alzheimer's disease	2.02e-05	7.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.02e-05	7.48e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PLCB1—Alzheimer's disease	2e-05	7.43e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GSK3B—Alzheimer's disease	2e-05	7.42e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—INS—Alzheimer's disease	1.98e-05	7.37e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CREB1—Alzheimer's disease	1.98e-05	7.36e-05	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.98e-05	7.36e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—INS—Alzheimer's disease	1.97e-05	7.32e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—Alzheimer's disease	1.97e-05	7.3e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CASP3—Alzheimer's disease	1.96e-05	7.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.96e-05	7.28e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GSK3B—Alzheimer's disease	1.96e-05	7.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GSK3B—Alzheimer's disease	1.96e-05	7.26e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK8—Alzheimer's disease	1.95e-05	7.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.95e-05	7.25e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—Alzheimer's disease	1.95e-05	7.24e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-05	7.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO1—Alzheimer's disease	1.95e-05	7.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS1—Alzheimer's disease	1.95e-05	7.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.95e-05	7.23e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—HMOX1—Alzheimer's disease	1.95e-05	7.22e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BCHE—Alzheimer's disease	1.94e-05	7.21e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-05	7.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-05	7.2e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCL2—Alzheimer's disease	1.94e-05	7.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCA1—Alzheimer's disease	1.94e-05	7.2e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—INS—Alzheimer's disease	1.93e-05	7.16e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—INS—Alzheimer's disease	1.93e-05	7.16e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP2D6—Alzheimer's disease	1.91e-05	7.09e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—Alzheimer's disease	1.91e-05	7.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.9e-05	7.06e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTGS2—Alzheimer's disease	1.9e-05	7.06e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCL2—Alzheimer's disease	1.9e-05	7.05e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCL2—Alzheimer's disease	1.9e-05	7.05e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—Alzheimer's disease	1.87e-05	6.93e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—Alzheimer's disease	1.87e-05	6.93e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	1.83e-05	6.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BCHE—Alzheimer's disease	1.81e-05	6.72e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—Alzheimer's disease	1.8e-05	6.7e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK8—Alzheimer's disease	1.8e-05	6.7e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—Alzheimer's disease	1.8e-05	6.68e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—LPL—Alzheimer's disease	1.78e-05	6.61e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	1.78e-05	6.6e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PPARG—Alzheimer's disease	1.77e-05	6.58e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	1.77e-05	6.56e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	1.76e-05	6.53e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—NOS3—Alzheimer's disease	1.74e-05	6.46e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.74e-05	6.46e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—INS—Alzheimer's disease	1.74e-05	6.45e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOS3—Alzheimer's disease	1.73e-05	6.42e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLCB1—Alzheimer's disease	1.71e-05	6.34e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-05	6.28e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-05	6.28e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARGC1A—Alzheimer's disease	1.67e-05	6.2e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-05	6.18e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HMOX1—Alzheimer's disease	1.66e-05	6.18e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—Alzheimer's disease	1.66e-05	6.17e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-05	6.15e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCA1—Alzheimer's disease	1.66e-05	6.15e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—Alzheimer's disease	1.62e-05	6.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.61e-05	5.97e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—Alzheimer's disease	1.6e-05	5.95e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—Alzheimer's disease	1.59e-05	5.91e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—Alzheimer's disease	1.55e-05	5.74e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	1.53e-05	5.69e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—Alzheimer's disease	1.53e-05	5.68e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NOS3—Alzheimer's disease	1.52e-05	5.66e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	1.52e-05	5.66e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—LPL—Alzheimer's disease	1.52e-05	5.65e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—Alzheimer's disease	1.52e-05	5.64e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.5e-05	5.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	1.5e-05	5.56e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOE—Alzheimer's disease	1.49e-05	5.54e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—Alzheimer's disease	1.48e-05	5.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	1.48e-05	5.49e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—Alzheimer's disease	1.47e-05	5.45e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—Alzheimer's disease	1.46e-05	5.41e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-05	5.38e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-05	5.38e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.45e-05	5.37e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-05	5.33e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-05	5.33e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-05	5.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-05	5.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARGC1A—Alzheimer's disease	1.43e-05	5.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—Alzheimer's disease	1.42e-05	5.27e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—Alzheimer's disease	1.4e-05	5.21e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—Alzheimer's disease	1.39e-05	5.18e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—LPL—Alzheimer's disease	1.39e-05	5.18e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—Alzheimer's disease	1.37e-05	5.1e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	1.37e-05	5.09e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—Alzheimer's disease	1.37e-05	5.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.37e-05	5.07e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—Alzheimer's disease	1.36e-05	5.06e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.35e-05	5.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—Alzheimer's disease	1.35e-05	5.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.35e-05	5e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—Alzheimer's disease	1.35e-05	4.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.34e-05	4.96e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-05	4.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-05	4.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-05	4.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-05	4.89e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—LPL—Alzheimer's disease	1.3e-05	4.82e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	1.3e-05	4.82e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	1.28e-05	4.75e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—Alzheimer's disease	1.28e-05	4.73e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—INS—Alzheimer's disease	1.27e-05	4.73e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	1.26e-05	4.69e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—Alzheimer's disease	1.26e-05	4.67e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	1.26e-05	4.66e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.25e-05	4.66e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.25e-05	4.66e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—Alzheimer's disease	1.25e-05	4.63e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—Alzheimer's disease	1.25e-05	4.62e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-05	4.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-05	4.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.2e-05	4.46e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.17e-05	4.36e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CALM1—Alzheimer's disease	1.17e-05	4.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—Alzheimer's disease	1.17e-05	4.34e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—Alzheimer's disease	1.17e-05	4.34e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAV1—Alzheimer's disease	1.16e-05	4.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	4.3e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—Alzheimer's disease	1.15e-05	4.28e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-05	4.28e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—INS—Alzheimer's disease	1.15e-05	4.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.14e-05	4.25e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-05	4.24e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.13e-05	4.21e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-05	4.15e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-05	4.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.12e-05	4.15e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	1.12e-05	4.15e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	1.11e-05	4.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CALM1—Alzheimer's disease	1.09e-05	4.06e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—INS—Alzheimer's disease	1.09e-05	4.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—Alzheimer's disease	1.09e-05	4.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAV1—Alzheimer's disease	1.08e-05	4.01e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—Alzheimer's disease	1.06e-05	3.95e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—Alzheimer's disease	1.04e-05	3.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	1.02e-05	3.79e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—Alzheimer's disease	1.02e-05	3.78e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.01e-05	3.75e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INS—Alzheimer's disease	9.98e-06	3.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.97e-06	3.7e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACHE—Alzheimer's disease	9.72e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	9.61e-06	3.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	9.55e-06	3.55e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—Alzheimer's disease	9.55e-06	3.55e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—Alzheimer's disease	9.49e-06	3.52e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—Alzheimer's disease	9.41e-06	3.49e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INS—Alzheimer's disease	9.31e-06	3.45e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	9.24e-06	3.43e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—Alzheimer's disease	9.21e-06	3.42e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—Alzheimer's disease	9.21e-06	3.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	9.11e-06	3.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO1—Alzheimer's disease	9.11e-06	3.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	8.94e-06	3.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—Alzheimer's disease	8.75e-06	3.25e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	8.74e-06	3.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—Alzheimer's disease	8.61e-06	3.2e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—Alzheimer's disease	8.47e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—Alzheimer's disease	8.43e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—Alzheimer's disease	8.43e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—Alzheimer's disease	8.16e-06	3.03e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	8.01e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—Alzheimer's disease	8e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	7.99e-06	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—Alzheimer's disease	7.95e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.84e-06	2.91e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—Alzheimer's disease	7.78e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—Alzheimer's disease	7.78e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	7.75e-06	2.88e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—Alzheimer's disease	7.46e-06	2.77e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—Alzheimer's disease	7.01e-06	2.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	6.68e-06	2.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	6.65e-06	2.47e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPL—Alzheimer's disease	6.08e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	5.47e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	5.14e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CALM1—Alzheimer's disease	5.11e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—Alzheimer's disease	5.1e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAV1—Alzheimer's disease	5.05e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—Alzheimer's disease	4.64e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—Alzheimer's disease	4.44e-06	1.65e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	4.39e-06	1.63e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INS—Alzheimer's disease	4.35e-06	1.62e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—Alzheimer's disease	4.02e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.82e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—Alzheimer's disease	3.75e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3.49e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.76e-06	6.52e-06	CbGpPWpGaD
